Company

Our purpose is to uphold the highest standards of quality and compliance in delivering solutions to enhance patient’s quality of life.

Vision

Our Vision is to be global leader in high-quality Biomimetic devices and regenerative surgery, enhancing the healthcare landscape with our reliable and innovative solutions.

Our Mission is to design, develop, and distribute state-of-the-art therapies for bone and joint regeneration, providing innovative, and even personalized, solutions for patients worldwide.

Mission

We Believe in Our Values

Quality & Scientific Excellence

Quality & Scientific Excellence

We relentlessly pursue Made in Italy excellence in biomaterials and regenerative techniques, setting new benchmarks in quality and innovation.

Passion for Science & Expertise

Passion for Science & Expertise

Bridging ancient ceramics with modern biomaterials, our passion fuels pioneering advancements in regenerative surgery.

Compliance & Transparency

Compliance & Transparency

Our commitment to ethics and transparency ensures the safety and integrity of our innovative products and services.

Social Responsibility & Personal Care

Social Responsibility & Personal Care

We focus on human needs, delivering impactful solutions for patients and surgeons.

Teamwork & Partnership

Teamwork & Partnership

Our strength lies in a dynamic, expert team working in unison, built on a foundation of trust and collaboration, including business partner.

Finceramica

Our Story

Finceramica develops and markets pioneering biomimetic solutions that have transformed the landscape of regenerative surgery. Our research efforts are focused on patient and surgeon needs, addressing challenges in orthopedic, spine, neurosurgery, and maxillofacial surgery.

1987

Finceramica was founded as a spin-off of the Institute of Science and Technology of Ceramic Materials of the CNR, initiated by a researcher specializing in the biomedical field.

1992

The company became operational with the entry of Federico, Adriano, and Giovanni Tampieri into the capital, marking the beginning of its production activities.

1998

Finceramica launched its first products on the market, establishing its presence in the biomedical sector.

2003

The company achieved its first international certifications, ensuring the quality and safety of its products.

2005

The Tampieri Group acquired full ownership of Finceramica, initiating a phase of significant commercial growth and product range expansion.

2007

Finceramica signed key agreements with leading companies in the biomedical sector, expanding its international footprint.

2010

The company introduced new technologies into its production processes, enhancing the effectiveness of its medical devices.

2015

Finceramica initiated collaborations with research institutes to develop new solutions in regenerative surgery.

2024

Finceramica celebrated 30 years of innovation, with an international network of experts and a strong global presence.

Today

The company continues to develop innovative therapeutic solutions, with a focus on biomaterials and regenerative surgery, maintaining research as a cornerstone of its activities.

Biomaterials
What are

Biomaterials?

A biomaterial is any substance, natural or artificial that has been engineered to treat, repair or replace any tissue, organ or function of the body.

Being similar from a chemical and structural point of view to the human tissues, these materials have the peculiar feature of favouring the regeneration of physiological tissues.

Finceramica biomaterial products are made of hydroxyapatite, the bioceramic material which makes up 70% of the human bone. Once implanted, hydroxyapatite-based biomaterials form an ideal micro-environment to biologically support the development of the new bone.

Our Family

Family

Finceramica’s Family is made up of young, dinamic and forward-looking teams which communicate and operate within an international network.

We are strong believers in teamwork, especially in the biomedical field. We collaborate together with a multidisciplinary approach to reach Finceramica success on a Global scale.

Our corporate structure is designed to develop new biotechnologies with a unique focus: the customer-oriented approach.

People employed
Average age of the team
% of women in the team
% of man in the team
Code ethics
Code of ethics

Ethics matter to us

Our integrity resonates within every action we take and guides us to achieve our corporate goals.

Therefore, Finceramica has decided to adhere to the principles laid out in
Legislative Decree 231/01 of the Italian Law, adopting an organizational model and availing themselves of a supervisory body.
The organizational model is based on the Code of Ethics, which is the main tool for implementing ethics within the company.

Our sustainability

Innovation for Global Wellbeing

Finceramica is a sustainable company, seeking a balance between economic, social and environmental aspects. We care about enviromental development and safeguard and we also pay attention to workplace safety and workers’ rights.
We are focused on the evolution of truly useful products and services, able to guarantee an high quality of life for patients.
Our innovative biomimetic products made of bioceramic materials belongs to the Faenza ceramic hub, which promotes territory evolution.

We are working on it…
Sustainability goals

CERAMIC AS PART OF OUR EVERYDAY PATH TO SUSTAINABILITY

Ceramic is a material that respects the environment starting from the natural raw materials used, which are processed in production cycles characterized by low environmental impact, to become products that by intrinsic characteristics and by their intended use protect environmental sustainability.

Certifications
Certifications

Ethics matter to us.

Finceramica’s quality system is organized according to the requirements:

  • ISO 9001
  • ISO 13485
  • 21CFR 820


The priority of Finceramica is the achievement of a high level of quality applied to the products and services provided.

The company also implements a quality policy aimed at continuous improvement to maintain a leadership position on the market and to ensure its customers safe and innovative products and services. Below, you will find the management declaration and quality policy, signed by the CEO.

We are Finceramica

We are expanding our brand and values around the world. Since 2003, we have reached 63 countries with our products: CustomBone, CustomizedBone, MaioRegen, RegenOss, ENGIpore and SINTlife.
In Italy, where Finceramica is based, more than 90 neurosurgeries and the large orthopedic centers have relied on us.

We are Finceramica

Nuova Zelanda, Malta, Messico, South Korea, San Marino, Bahrain, Singapore, Luxembourg, Georgia, Rwanda, Tunisia, Serbia, Morocco, Hong Kong, Hungary, Cile, Croatia, Latvia, Kenia, Lebanon, Saudi Arabia, Qatar, Portugal, Argentina, Denmark, Romania, South Africa, Malaysia, Cipro, Norway, Perù, Iran, Lithuania, U.S.A., Oman, Sweden, Kuwait, United Arab Emirates, Colombia, Israel, Turkey, Czech Republic, Austria, Slovakia, Netherlands, Poland, Slovenia, Australia, Switzerland, Russian Federation, Greece, Germany, Spain, Ireland, United Kingdom, Belgium, France, Italy, Qwait, Yemen, Bulgaria, Canada, Finland,

95

Neurosurgery centers in Italy

63

Countries

1500

Languages spoken

1.92

Billions of people covered

Press kit

DOWNLOAD PRESS KIT